Morningstar Investment Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.24M Hold
48,878
0.26% 89
2026
Q1
$4.24M Buy
48,878
+4,556
+10% +$436K 0.26% 89
2025
Q4
$4.26M Sell
44,322
-669
-1% -$65K 0.25% 90
2025
Q3
$4.29M Buy
44,991
+22,229
+98% +$2.04M 0.16% 154
2025
Q2
$1.98M Buy
22,762
+1,712
+8% +$145K 0.17% 37
2025
Q1
$1.89M Buy
21,050
+2,454
+13% +$220K 0.16% 41
2024
Q4
$1.49M Buy
18,596
+528
+3% +$45.7K 0.12% 51
2024
Q3
$1.63M Buy
18,068
+6,853
+61% +$577K 0.16% 56
2024
Q2
$883K Hold
11,215
0.09% 91
2024
Q1
$977K Hold
11,215
0.11% 83
2023
Q4
$924K Sell
11,215
-824
-7% -$62.8K 0.11% 86
2023
Q3
$943K Buy
12,039
+275
+2% +$23K 0.13% 60
2023
Q2
$1.04M Buy
11,764
+4,979
+73% +$429K 0.14% 57
2023
Q1
$547K Buy
6,785
+381
+6% +$31.1K 0.08% 53
2022
Q4
$498K Buy
+6,404
New +$519K 0.08% 57

Other funds holding MDT

Morningstar Investment Management's MDT Position: Q2 2026 in Review

Morningstar Investment Management held its Medtronic (MDT) position steady in Q2 2026 at 48,878 shares worth $4.24M. The position accounts for 0.26% of the portfolio, ranked #89.

Morningstar Investment Management first reported a position in MDT in Q4 2022 and has held it in 15 quarters since. The position peaked at $4.29M in Q3 2025. 901 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Morningstar Investment Management held 48,878 shares of Medtronic worth $4.24M as of Q2 2026.
  • Morningstar Investment Management left its Medtronic share count unchanged in Q2 2026.
  • Medtronic made up 0.26% of Morningstar Investment Management's portfolio in Q2 2026, its #89 holding.
  • Morningstar Investment Management first reported a position in Medtronic in Q4 2022 and has held it in 15 quarters since.
  • Morningstar Investment Management's Medtronic position peaked at $4.29M in Q3 2025.
  • 901 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Morningstar Investment Management's 13F filing for Q2 2026, filed 21 Jul 2026.